ISIS Share Price

Open 58.27 Change Price %
High 58.45 1 Day -0.28 -0.48
Low 56.70 1 Week 0.00 0.00
Close 57.56 1 Month 0.00 0.00
Volume 987322 1 Year 0.00 0.00
52 Week High 22.76
52 Week Low 18.19
ISIS Important Levels
Resistance 2 59.18
Resistance 1 58.51
Pivot 57.57
Support 1 56.61
Support 2 55.94
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DCTH 0.13 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.03 50.00%
LOCM 0.09 50.00%
VRTA 4.50 38.46%
ATEA 2.50 32.98%
ATEA 2.50 32.98%
KIRK 10.98 31.03%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
TWER 0.10 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS)

ISIS Technical Analysis 1.5
As on 21st Dec 2015 ISIS Share Price closed @ 57.56 and we RECOMMEND Sell for LONG-TERM with Stoploss of 58.88 & Buy for SHORT-TERM with Stoploss of 53.45 we also expect STOCK to react on Following IMPORTANT LEVELS.
ISIS Target for August
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
ISIS Other Details
Segment EQ
Market Capital 813884480.00
Sector Healthcare
Industry Drug Manufacturers - Other
Offical website http://www.isispharm.com
ISIS Address
ISIS
2855 Gazelle Court
Carlsbad, CA 92010
United States
Phone: 760-931-9200
ISIS Latest News
Interactive Technical Analysis Chart Isis Pharmaceuticals, Inc. ( ISIS NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Isis Pharmaceuticals, Inc.
ISIS Business Profile
Isis Pharmaceuticals, Inc. develops therapeutic drugs inhibiting cell protein synthesis. The Company's principal activity is to develop and market RNA(RiboNucleicAcid)-based novel drugs to treat important diseases such as cardiovascular diseases, diabetes and asthma